The percentage of CD4+ T helper cells (Figure 4B) in grade IV glioma patients at first diagnosis, but not that of CD3+/CD8+ cytotoxic T cells (Figure 4C), was significantly lower than in healthy controls (ANOVA, post-hoc Tukey test, *p < 0.05). Here, CD4 is linked to central nervous system cancer.